Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,000 | 2 | 67.6% |
| Food and Beverage | $1,435 | 15 | 32.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dilon Technologies, Inc. | $3,468 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $467.99 | 4 | $0 (2024) |
| Biom'Up France SAS | $128.95 | 1 | $0 (2020) |
| TESARO, Inc. | $125.00 | 1 | $0 (2018) |
| DAVOL INC. | $119.46 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $38.76 | 1 | $0 (2022) |
| Integra LifeSciences Corporation | $28.91 | 1 | $0 (2022) |
| AbbVie, Inc. | $23.97 | 1 | $0 (2017) |
| Medtronic, Inc. | $19.47 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $15.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.91 | 2 | Dilon Technologies, Inc. ($165.18) |
| 2023 | $3,302 | 4 | Dilon Technologies, Inc. ($3,302) |
| 2022 | $236.59 | 5 | AstraZeneca Pharmaceuticals LP ($134.32) |
| 2021 | $124.97 | 1 | AstraZeneca Pharmaceuticals LP ($124.97) |
| 2020 | $128.95 | 1 | Biom'Up France SAS ($128.95) |
| 2019 | $244.43 | 2 | AstraZeneca Pharmaceuticals LP ($124.97) |
| 2018 | $125.00 | 1 | TESARO, Inc. ($125.00) |
| 2017 | $23.97 | 1 | AbbVie, Inc. ($23.97) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $83.73 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $165.18 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 09/01/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 06/14/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $162.57 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 05/15/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 04/25/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $139.87 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 12/14/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $38.76 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $134.32 | General |
| Category: Oncology | ||||||
| 06/27/2022 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, CODMAN HAKIM | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Neuro Critical Care | ||||||
| 06/15/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Drug Infusion Systems | ||||||
| 03/16/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Oncology | ||||||
| 02/06/2020 | Biom'Up France SAS | HemoBlast Bellows (Device) | Food and Beverage | In-kind items and services | $128.95 | General |
| Category: Hemostatic Agent | ||||||
| 05/23/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Oncology | ||||||
| 05/17/2019 | DAVOL INC. | PROGEL (Device) | Food and Beverage | In-kind items and services | $119.46 | General |
| Category: INTERVENTIONAL | ||||||
| 08/07/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 96 | 115 | $20,654 | $9,143 |
| 2022 | 4 | 57 | 66 | $42,309 | $13,082 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $10,419 | $3,939 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 50 | $5,725 | $2,944 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 18 | $2,987 | $1,628 | 54.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,523 | $632.26 | 41.5% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 11 | 11 | $30,352 | $7,386 | 24.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $7,294 | $3,240 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $2,489 | $1,342 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 19 | $2,175 | $1,115 | 51.2% |
About Evan Smith
Evan Smith is a Gynecologic Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2013. The National Provider Identifier (NPI) number assigned to this provider is 1972948958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Evan Smith has received a total of $4,435 in payments from pharmaceutical and medical device companies, with $248.91 received in 2024. These payments were reported across 17 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($3,000).
As a Medicare-enrolled provider, Smith has provided services to 153 Medicare beneficiaries, totaling 181 services with total Medicare billing of $22,225. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Gynecologic Oncology
- Location New York, NY
- Active Since 05/06/2013
- Last Updated 12/29/2023
- Taxonomy Code 207VX0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972948958
Products in Payments
- HEMOBLAST BELLOWS (Device) $3,468
- LYNPARZA (Drug) $467.99
- ZEJULA (Drug) $163.76
- HemoBlast Bellows (Device) $128.95
- PROGEL (Device) $119.46
- CODMAN CERTAS (Device) $28.91
- Lupron (Drug) $23.97
- SYNCHROMEDII (Device) $19.47
- KEYTRUDA (Biological) $15.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in New York
Bhavana Pothuri, M.d, M.D
Gynecologic Oncology — Payments: $299,385
Mario Leitao, M.d, M.D
Gynecologic Oncology — Payments: $132,719
Dr. Konstantin Zakashansky, M.d, M.D
Gynecologic Oncology — Payments: $113,159
Evelyn Cantillo, M.d, M.D
Gynecologic Oncology — Payments: $78,767
Dr. Jeff Lin, M.d, M.D
Gynecologic Oncology — Payments: $36,366
Dr. Nimesh Nagarsheth, M.d, M.D
Gynecologic Oncology — Payments: $35,225